The Role of Neighborhood Air Pollution Exposure on Somatic Non-Small Cell Lung Cancer Mutations in the Los Angeles Basin (2013–2018)
暂无分享,去创建一个
Marta M. Jankowska | Jiue-An Yang | S. Gray | T. Benmarhnia | L. Erhunmwunsee | Sam E. Wing | N. Letellier | Noémie Letellier
[1] Jun Wu,et al. Using machine learning to estimate wildfire PM2.5 at California ZIP codes (2006-2020) , 2021 .
[2] R. Kittles,et al. The Association between Polluted Neighborhoods and TP53-Mutated Non–Small Cell Lung Cancer , 2021, Cancer Epidemiology, Biomarkers & Prevention.
[3] H. Hou,et al. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis , 2019, BMC Cancer.
[4] Junchao Duan,et al. PM2.5-induced alteration of DNA methylation and RNA-transcription are associated with inflammatory response and lung injury. , 2019, The Science of the total environment.
[5] J. Shim,et al. Long-Term Exposure to Air Pollutants and Cancer Mortality: A Meta-Analysis of Cohort Studies , 2018, International journal of environmental research and public health.
[6] William R. Buckingham,et al. Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas. , 2018, The New England journal of medicine.
[7] Jiange Zhang,et al. Function of PM2.5 in the pathogenesis of lung cancer and chronic airway inflammatory diseases. , 2018, Oncology letters.
[8] Xiaozhen Liu,et al. Characterization of distinct types of KRAS mutation and its impact on first-line platinum-based chemotherapy in Chinese patients with advanced non-small cell lung cancer , 2017, Oncology Letters.
[9] C. Bai,et al. Particulate matter‐induced epigenetic changes and lung cancer , 2017, The clinical respiratory journal.
[10] Thomas Efferth,et al. The role of p53 in cancer drug resistance and targeted chemotherapy , 2016, Oncotarget.
[11] S. Couraud,et al. Somatic alterations in lung cancer: Do environmental factors matter? , 2016, Lung cancer.
[12] P. Gosset,et al. In vitro short-term exposure to air pollution PM2.5-0.3 induced cell cycle alterations and genetic instability in a human lung cell coculture model. , 2016, Environmental research.
[13] Oa Us Epa. Particulate Matter (PM) Basics , 2016 .
[14] Wei Zhou,et al. Repeated PM2.5 exposure inhibits BEAS-2B cell P53 expression through ROS-Akt-DNMT3B pathway-mediated promoter hypermethylation , 2016, Oncotarget.
[15] M. Chenard,et al. Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases , 2015, British Journal of Cancer.
[16] A. Cohen,et al. Lung Cancer and Exposure to Nitrogen Dioxide and Traffic: A Systematic Review and Meta-Analysis , 2015, Environmental health perspectives.
[17] Ping Wang,et al. Characterization of Somatic Mutations in Air Pollution-Related Lung Cancer , 2015, EBioMedicine.
[18] F. Song,et al. Ambient particulate matter and lung cancer incidence and mortality: a meta-analysis of prospective studies. , 2015, European journal of public health.
[19] P. Catalano,et al. Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer. , 2015, Clinical lung cancer.
[20] D. Beer,et al. KRAS-G12C Mutation Is Associated with Poor Outcome in Surgically Resected Lung Adenocarcinoma , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[21] Paolo Vineis,et al. Outdoor Particulate Matter Exposure and Lung Cancer: A Systematic Review and Meta-Analysis , 2014, Environmental health perspectives.
[22] L. Byers,et al. Smoking, p53 Mutation, and Lung Cancer , 2014, Molecular Cancer Research.
[23] Marina Camatini,et al. Cell cycle alterations induced by urban PM2.5 in bronchial epithelial cells: characterization of the process and possible mechanisms involved , 2013, Particle and Fibre Toxicology.
[24] B. Brunekreef,et al. Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). , 2013, The Lancet. Oncology.
[25] M. Ladanyi,et al. Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas , 2013, Cancer.
[26] M. Ladanyi,et al. Lungs Don’t Forget: Comparison of the KRAS and EGFR Mutation Profile and Survival of Collegiate Smokers and Never Smokers with Advanced Lung Cancers , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[27] Daniel Krewski,et al. Estimates of global mortality attributable to particulate air pollution using satellite imagery. , 2013, Environmental research.
[28] C. Pope,et al. Long-term ambient fine particulate matter air pollution and lung cancer in a large cohort of never-smokers. , 2011, American journal of respiratory and critical care medicine.
[29] Stef van Buuren,et al. MICE: Multivariate Imputation by Chained Equations in R , 2011 .
[30] N. Ridgway,et al. Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update. , 2011, Journal of thoracic disease.
[31] J. Kucab,et al. Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock‐in (Hupki) mouse model , 2010, The FEBS journal.
[32] B. Hubbell,et al. Overview of the Quantitative Risk Assessment for the Current Review of the National Ambient Air Quality Standards (NAAQS) for PM , 2010 .
[33] M. Hollstein,et al. The carcinogenic air pollutant 3-nitrobenzanthrone induces GC to TA transversion mutations in human p53 sequences. , 2008, Mutagenesis.
[34] A. Valavanidis,et al. Airborne Particulate Matter and Human Health: Toxicological Assessment and Importance of Size and Composition of Particles for Oxidative Damage and Carcinogenic Mechanisms , 2008, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.
[35] B. Rannala,et al. TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factors. , 2008, Cancer genetics and cytogenetics.
[36] R. Burnett,et al. Further interpretation of the acute effect of nitrogen dioxide observed in Canadian time-series studies , 2007, Journal of Exposure Science and Environmental Epidemiology.
[37] T. Dann,et al. Ambient air 1,3-butadiene concentrations in Canada (1995–2003): seasonal, day of week variations, trends, and source influences , 2006 .
[38] H. Varmus,et al. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib , 2005, PLoS medicine.
[39] R. Burnett,et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. , 2002, JAMA.